Multifunctional PEGylated Niosomal Nanoparticle-Loaded Herbal Drugs as a Novel Nano-Radiosensitizer and Stimuli-Sensitive Nanocarrier for Synergistic Cancer Therapy.

Nowadays, radiotherapy is one of the most effective treatments for breast cancer. In order to overcome the radioresistance of cancer cells, radio-sensitizing agents can be used combined with irradiation to increase the therapeutic efficiency. Curcumin can enhance the radiosensitivity of cancer cells and decrease their viability by the accumulation of these cells in the G2 phase. The encapsulation of curcumin in a nanoniosomal delivery system increases aqueous solubility and bioavailability, resulting in increased radio sensitivity. The present study aimed to enhance the radio-sensitizing effect of the curcumin-containing nanoniosome (Cur-Nio) when combined with irradiation. Thus, curcumin (0.5 mg ml-1) was loaded on a PEGylated nanoniosome containing Tween 60, cholesterol, DOTAP, and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-poly(ethylene glycol) (DSPE-PEG) (at ratios of 70:30:10:5, respectively) by the thin-film hydration method. The particle size, zeta potential, entrapment efficiency, and drug-release rate of formulated nanoniosomes were determined. In order to assess cytotoxicity and apoptosis, different doses of irradiation along with various concentrations of free curcumin and Cur-Nio (single or in combination with irradiation) were treated with breast cancer cells. The particle size and zeta potential of Cur-Nio were reported to be 117.5 nm and -15.1 mV, respectively. The entrapment efficiency (EE%) and loading capacities were 72.3% and 6.68%, respectively. The drug-release rate during 6 h was 65.9%. Cell survival in the presence of curcumin at doses of 1 and 3 Gy showed a significant reduction compared with cells irradiated at 48 h and 72 h (p < 0.000). Also, the rate of cytotoxicity and apoptosis was significantly higher in cells treated with the combination of curcumin-containing nanoniosomes and irradiation in comparison with those treated with free curcumin. These findings indicate that the efficacy of pre-treatment with Cur-Nio as a radiosensitizer during radiotherapy enhances irradiation-induced breast cancer cell apoptosis and is a useful strategy to increase the effectiveness of breast cancer therapy.

Monte Carlo evaluation of effective dose and risk of exposure induced cancer death (REID) for common examinations in stereo radiography (EOS) imaging: Considering age and gender.

INTRODUCTION: The aim of this study is to evaluate the effective dose and cancer risk of examinations in EOS imaging system in different age and gender groups. MATERIALS AND METHODS: In total, 555 patients who had undergone common EOS imaging examinations were entered into the study. Exposure parameters and patients' characteristics for lower limb, full spine and full body imaging techniques, at different gender and age groups, were evaluated. Finally, effective dose and risk of exposure induced cancer death (REID) was calculated with the Monte Carlo based PCXMC software. RESULTS: The difference between average effective doses of male and female was not significant (p ≥ 0.05), however, the corresponding REID showed statistically significant difference (p ≤ 0.001). The average effective dose of patients (without considering technique, age and gender) was obtained as 0.13 mSv. The corresponding average REID was 8.84 per million. The maximum average effective dose value was obtained for patients over 10 years of age with the full body technique (0.17 ± 0.05 mSv). The maximum average REID value was obtained for full body technique and for patient with 0-10 years old (15.20 ± 10.00 per million). CONCLUSION: In common EOS imaging examinations, the effective dose and REID values of patients in both genders in all age groups are less than the corresponding values in other imaging modalities (according to previous studies). However, according to stochastic effects of ionizing radiation and based on the As Low As Reasonably Achievable (ALARA) principle, more considerations are necessary, especially in the full body technique and for female examinations.

Equivalent Dose and Risk of Exposure Induced Cancer Death of Different Organs due to Various Image Techniques of EOS Imaging System.

BACKGROUND: Euronext Paris Advanced Orthopedic Solutions (EOS) system is a new radiography system, capable of obtaining two-dimensional and three-dimensional images from bony structures in the body. OBJECTIVE: The aim of this study is to estimate equivalent dose and the risk of exposure induced cancer death (REID) in different organs of body due to EOS imaging system. MATERIAL AND METHODS: In this experimental study, totally 120 patients were evaluated for various imaging techniques of lower limb, full spine and whole body. Equivalent dose and REID for colon, liver, lung, stomach, breast, bladder, ovary, blood cells (leukemia) and other organs were calculated using PCXMC software (version 2.0.1.2) based on Monte Carlo simulation of X-ray and human phantoms. The data on imaging technique, including age, sex, kVp, dose area product (DAP), mA, focal to detector distance were introduced as the input of PCXMC. RESULTS: The maximum equivalent dose (mSv) due to EOS imaging system, was estimated for the bladder 0.240±0.066 for the full body technique and 0.240±0.093 for the lower limb technique, respectively, in both males and females. The maximum organ REID (incidence per million) due to EOS imaging system was estimated for lungs as 2.59±1.0 and 2.53±0.9, for the full body technique in both males and females, respectively. CONCLUSION: Generally, the equivalent dose and REID by EOS imaging system in different organs of body is low due to the low radiation dose received by the body in different techniques and views.